Login

Componenta as an Investment - Investor Day 28.11.2022| Sami Sivuranta , CEO of Componenta 00:10:00

Share On Facebook Share On Twitter

Sami Sivuranta is President/CEO/IR at Componenta OYJ.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The pandemic accelerated our focus on operational resilience and digital transformation.
00:10:00
Inflection Resources Targets Tier One Copper-Gold Deposits in New South Wales
00:10:00
Matthew Continetti on Teaching American Conservatism at American University|Matthew Continetti,Professor,American Enterprise Institute
00:00:00
Noxopharm CEO talks Veyonda orphan drug designation from US FDA - Dr Gisela Mautner Chief Executive Officer and Managing Director, Noxopharm Ltd
00:10:00
Pebble Valley Wealth Management: Your Partner in Financial Planning
00:10:00
An interview with Aferian plc CEO Donald McGarva | Donald McGarva, CEO, Aferian PLCAFRN:LSE
00:10:00
How AI is Changing Business|Ankit Jain, Founding Partner, Gradient Ventures
00:10:00
PSALM awarded the 165-MW Casecnan hydroelectric power plant to a First Gen subsidiary, as reported by ANC.
00:10:00
The Founder's Compass: IVP - Guiding Breakout Companies to Market Leadership|Cack Wilhelm,General Partner,IVP
00:10:00
Thomas Wynn, Managing Director at MacKay Shields, predicts that a rise in rates will lead to increased volatility, impacting convertibles.|Naïm Abou-Jaoudé currently serves as Chairman and Interim CEO of MacKay Shields and is the Chief Executive Officer o
00:10:00
Exploration investment is rising, according to CGG CEO | Sophie Zurquiyah, CEO, CGG SACGG:PAR
00:10:00
Insights into Macro Trends and Investment Strategy: A Discussion with Karen Karniol-Tambour, Co-CIO of Bridgewater Associates, at GIC Insights 2023

© 2017 - Neuhu+